Comparison of plasma, venous and capillary blood levels of piperaquine in patients with uncomplicated falciparum malaria.

Comparison of plasma, venous and capillary blood levels of piperaquine in patients with uncomplicated falciparum malaria.

Toon andere (1) versies

PURPOSE: Dihydroartemisinin-piperaquine (DP) is a fixed-dose artemisinin-based combination treatment. Field pharmacokinetic studies would be simplified and facilitated by being able to use small volume capillary assays rather than venous blood. The aim of this study was to describe the relationship...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Ashley, E, Stepniewska, K, Lindegardh, N, Annerberg, A, Tarning, J, Mcgready, R, Phaiphun, L, Singhasivanon, P, White, N, Nosten, F
Formaat:	Journal article
Taal:	English
Gepubliceerd in:	2010

Gelijkaardige items

Comparison of plasma, venous and capillary blood levels of piperaquine in patients with uncomplicated falciparum malaria
door: Ashley, E, et al.
Gepubliceerd in: (2010)

Population pharmacokinetics of piperaquine after two different treatment regimens of dihydroartemisinin piperaquine in patients with acute uncomplicated falciparum malaria in Thailand
door: Tarning, J, et al.
Gepubliceerd in: (2007)

Pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated falciparum malaria.
door: Rijken, M, et al.
Gepubliceerd in: (2011)

Pharmacokinetics of piperaquine in pregnant women in Sudan with uncomplicated Plasmodium falciparum malaria.
door: Adam, I, et al.
Gepubliceerd in: (2012)

Population pharmacokinetics of piperaquine after two different treatment regimens with dihydroartemisinin-piperaquine in patients with Plasmodium falciparum malaria in Thailand.
door: Tarning, J, et al.
Gepubliceerd in: (2008)

Pharmacokinetics of piperaquine in pregnant women in Sudan with uncomplicated Plasmodium falciparum malaria
door: Adam, I, et al.
Gepubliceerd in: (2012)

Comparison of lumefantrine, mefloquine, and piperaquine concentrations between capillary plasma and venous plasma samples in pregnant women with uncomplicated falciparum and vivax malaria
door: Saito, M, et al.
Gepubliceerd in: (2024)

Population pharmacokinetic assessment of the effect of food on piperaquine bioavailability in patients with uncomplicated malaria.
door: Tarning, J, et al.
Gepubliceerd in: (2014)

Population pharmacokinetics of lumefantrine in pregnant women treated with artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria.
door: Tarning, J, et al.
Gepubliceerd in: (2009)

Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria.
door: Tarning, J, et al.
Gepubliceerd in: (2012)

Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria
door: Tarning, J, et al.
Gepubliceerd in: (2012)

The pharmacokinetics of artemether and lumefantrine in pregnant women with uncomplicated falciparum malaria.
door: Mcgready, R, et al.
Gepubliceerd in: (2006)

The pharmacokinetics of artemether and lumefantrine in pregnant women with uncomplicated falciparum malaria.
door: McGready, R, et al.
Gepubliceerd in: (2009)

Electrocardiographic safety evaluation of dihydroartemisinin piperaquine in the treatment of uncomplicated falciparum malaria.
door: Mytton, O, et al.
Gepubliceerd in: (2007)

Population pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated malaria.
door: Tarning, J, et al.
Gepubliceerd in: (2012)

Population Pharmacokinetics of Dihydroartemisinin and Piperaquine in Pregnant and Nonpregnant Women with Uncomplicated Malaria
door: Tarning, J, et al.
Gepubliceerd in: (2012)

Randomized, controlled dose-optimization studies of dihydroartemisinin-piperaquine for the treatment of uncomplicated multidrug-resistant falciparum malaria in Thailand.
door: Ashley, E, et al.
Gepubliceerd in: (2004)

Efficacy and day 7 plasma piperaquine concentrations in African children treated for uncomplicated malaria with dihydroartemisinin-piperaquine
door: Zongo, I, et al.
Gepubliceerd in: (2014)

A small amount of fat does not affect piperaquine exposure in patients with malaria.
door: Annerberg, A, et al.
Gepubliceerd in: (2011)

A small amount of fat does not affect piperaquine exposure in patients with malaria.
door: Annerberg, A, et al.
Gepubliceerd in: (2011)

A population pharmacokinetic model of piperaquine in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum malaria in Sudan.
door: Hoglund, R, et al.
Gepubliceerd in: (2012)

Pharmacokinetic study of artemether-lumefantrine given once daily for the treatment of uncomplicated multidrug-resistant falciparum malaria.
door: Ashley, E, et al.
Gepubliceerd in: (2007)

Pharmacokinetic study of artemether-lumefantrine given once daily for the treatment of uncomplicated multidrug-resistant falciparum malaria
door: Ashley, E, et al.
Gepubliceerd in: (2007)

A randomized, controlled study of a simple, once-daily regimen of dihydroartemisinin-piperaquine for the treatment of uncomplicated, multidrug-resistant falciparum malaria.
door: Ashley, E, et al.
Gepubliceerd in: (2005)

Population pharmacokinetic assessment of a new regimen of mefloquine used in combination treatment of uncomplicated falciparum malaria.
door: Ashley, E, et al.
Gepubliceerd in: (2006)

Efficacy and day 7 plasma piperaquine concentrations in African children treated for uncomplicated malaria with dihydroartemisinin-piperaquine.
door: Issaka Zongo, et al.
Gepubliceerd in: (2014-01-01)

A population pharmacokinetic model of piperaquine in pregnant and non-pregnant women with uncomplicated <it>Plasmodium falciparum</it> malaria in Sudan
door: Hoglund Richard M, et al.
Gepubliceerd in: (2012-11-01)

Erratum:The pharmacokinetics of artemether and lumefantrine in pregnant women with uncomplicated falciparum malaria(European Journal of Clinical Pharmacology (2006) 62 (1021-1031) DOI: 10.1007/s00228-006-0199-7)
door: Mcgready, R, et al.
Gepubliceerd in: (2009)

Quantification of the antimalarial piperaquine in plasma.
door: Tarning, J, et al.
Gepubliceerd in: (2008)

Pitfalls in estimating piperaquine elimination.
door: Tarning, J, et al.
Gepubliceerd in: (2005)

Dihydroartemisinin - piperaquine rescue treatment of multidrug-resistant Plasmodium falciparum malaria in pregnancy: a preliminary report
door: Rijken, M, et al.
Gepubliceerd in: (2007)

A randomised controlled trial of artemether-lumefantrine versus artesunate for uncomplicated plasmodium falciparum treatment in pregnancy.
door: Mcgready, R, et al.
Gepubliceerd in: (2008)

Pharmacokinetics of dihydroartemisinin following oral artesunate treatment of pregnant women with acute uncomplicated falciparum malaria.
door: Mcgready, R, et al.
Gepubliceerd in: (2006)

Optimal designs for population pharmacokinetic studies of oral artesunate in patients with uncomplicated falciparum malaria.
door: Jamsen, K, et al.
Gepubliceerd in: (2011)

Pharmacokinetic predictors for recurrent malaria after dihydroartemisinin-piperaquine treatment of uncomplicated malaria in Ugandan infants.
door: Creek, D, et al.
Gepubliceerd in: (2013)

Dihydroartemisinin-piperaquine rescue treatment of multidrug-resistant Plasmodium falciparum malaria in pregnancy: a preliminary report.
door: Rijken, M, et al.
Gepubliceerd in: (2008)

Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison.
door: Smithuis, F, et al.
Gepubliceerd in: (2006)

In vivo sensitivity monitoring of mefloquine monotherapy and artesunate-mefloquine combinations for the treatment of uncomplicated falciparum malaria in Thailand in 2003.
door: Ashley, E, et al.
Gepubliceerd in: (2006)

Randomized, double-blind, placebo-controlled trial of monthly versus bimonthly dihydroartemisinin-piperaquine chemoprevention in adults at high risk of malaria
door: Lwin, K, et al.
Gepubliceerd in: (2012)

Randomized, double-blind, placebo-controlled trial of monthly versus bimonthly dihydroartemisinin-piperaquine chemoprevention in adults at high risk of malaria.
door: Lwin, K, et al.
Gepubliceerd in: (2012)